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Abstract 
Background: It has been reported that USP7 (ubiquitin-specific protease 7) prevents ubiquitylation and degrada-
tion of DNA methyltransferase 1 (DNMT1) by direct binding of USP7 to the glycine-lysine (GK) repeats that join the 
N-terminal regulatory domain of DNMT1 to the C-terminal methyltransferase domain. The USP7-DNMT1 interaction 
was reported to be mediated by acetylation of lysine residues within the (GK) repeats.
Results: We found that DNMT1 is present at normal levels in mouse and human cells that contain undetectable 
levels of USP7. Substitution of the (GK) repeats by (GQ) repeats prevents lysine acetylation but does not affect the 
stability of DNMT1 or the ability of the mutant protein to restore genomic methylation levels when expressed in 
Dnmt1-null ES cells. Furthermore, both USP7 and PCNA are recruited to sites of DNA replication independently of the 
presence of DNMT1, and there is no evidence that DNMT1 is degraded in cycling cells after S phase.
Conclusions: Multiple lines of evidence indicate that homeostasis of DNMT1 in somatic cells is controlled primarily 
at the level of transcription and that interaction of USP7 with the (GK) repeats of DNMT1 is unlikely to play a major role 
in the stabilization of DNMT1 protein.
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Background
DNMT1 methylates hemimethylated CpG dinucleotides 
that appear after passage of the replication fork during 
S phase to ensure mitotic inheritance of genomic meth-
ylation patterns [1]. As shown in Fig. 1, DNMT1 bears a 
large N-terminal region that contains multiple functional 
domains that mediate nuclear import (the NLS domain), 
the suppression of de novo methylation (the CXXC and 
autoinhibitory domains) [2], two bromo-adjacent homol-
ogy (BAH) domains of unknown function, and glycine-
lysine (GK) repeats consisting of 13 alternating glycine 
and lysine residues. The (GK) repeats join the N-terminal 
regulatory domain to the C-terminal methyltransferase 
domain that is closely related in sequence and struc-
ture to DNA (cytosine-5) methyltransferases from both 
prokaryotes and eukaryotes [3]. The (GK) repeats are 
conserved among all eukaryotic DNMT1 homologs, all of 
which are lysine-rich and have at least one GK dipeptide 
between the regulatory and catalytic domains. GK dipep-
tides are also enriched in the N-terminal tails of histones 
H2A and H4 (Fig. 1c).
The structures of several mouse and human DNMT1 
proteins have been determined [2, 4–6], and in all cases, 
the (GK) repeats are disordered in the crystal structure 
and not resolved, which implies that they do not form 
stable associations with other domains of DNMT1. The 
approximate positions of the (GK) repeats with respect 
to other domains of DNMT1 are shown in Fig. 1d. It has 
been reported that the (GK) repeats are involved in con-
trolling proteasomal degradation of DNMT1 via revers-
ible acetylation of lysines within the (GK) repeats [7–11]; 
this has been suggested to couple DNMT1 biosynthesis 
and degradation to the cell cycle [9]. Ubiquitin-specific 
protease 7 (USP7; also known as Herpes-associated 
ubiquitin-specific protease or HAUSP) [12–14] has 
been reported to bind to the unacetylated (GK) repeats 
of DNMT1 [10]; the acetylated form was reported to be 
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incapable of binding to USP7 in vitro and has been pro-
posed to undergo ubiquitylation at lysine 586 (RFTS 
domain) and lysine 997 (BAH2 domain) [15], and to 
be targeted for proteasomal degradation [7]. DNMT1 
was also reported to be required for the recruitment of 
USP7 to sites of DNA replication in S phase nuclei [10]. 
These reports depended on the results of in vitro studies 
or transfection of tagged and mutated forms of DNMT1 
into cells that contained endogenous DNMT1; the rela-
tive levels of endogenous and exogenous DNMT1 were 
not reported and only exogenous DNMT1 was observed. 
Furthermore, levels of DNMT1 do not change appre-
ciably during the cell cycle [16], as shown in Fig.  1a, 
although DNMT1 is not expressed in  G0 cells [17]. We 
report here that reduction in USP7 to undetectable lev-
els in mouse and human cells did not cause a measurable 
reduction in content of DNMT1 or in DNA methyla-
tion, that substitution of the acetylated lysines within the 
(GK) repeats by glutamines does not affect the amount 
or activity of endogenous DNMT1, and that recruitment 
of USP7 to replication foci during S phase is independent 
of the presence of DNMT1. These and several other lines 
of evidence indicate that any USP7-DNMT1 interaction 
does not play a major role in the stabilization of DNMT1 




Mouse ES cells as described in [18] were cultured on 
gelatin following standard techniques. Stable ES cell 
lines were generated by nucleofection of Dnmt1-null ES 
cells [18] with MT80 minigene and pGKPuro plasmid 
for Puromycin resistance [19]. MT80 minigene, carry-
ing 12  kb of 5′ Dnmt1 genomic sequence with endog-
enous promoter and 5.5  kb of Dnmt1 cDNA [19, 20], 
was modified by the addition of an N-terminal Flag-HA 
tag after the translation start site. Point mutations were 
produced using QuikChange Site-Directed Mutagenesis 
kit (Agilent). Individual clones were selected with Puro-
mycin for 10–14  days and picked into 96-well plates. 
Clones were genotyped using primers specific to the 
Flag-HA tag. Positive clones were propagated, and levels 
of DNMT1 expression were tested by Western blotting. 
Clones expressing DNMT1 at wild-type levels were used 
for further studies.
Usp7  cl/+ mice [13] were intercrossed to generate 
homozygous conditional mutant embryos. MEFs were 
derived and transfected with a construct that expressed 
SV40 large T antigen. MEFs were subsequently infected 
with Ad–GFP and Ad–Cre–GFP viruses from Vector 
Biolabs (Catalogue numbers 1761 and 1710). Cultures 
that showed near-complete infection with Ad-Cre-GFP 
virus as assessed by visualization of GFP expression were 
analyzed after five days.
To generate the inducible Usp7 shRNA knockdown 
cells, H1299 cells were transfected with pTRIPZ encoding 
a Tet-inducible Usp7 short hairpin RNA obtained from 
Thermo Open Biosystems (clone ID: V2THS_172409) 
and a Puromycin resistance cassette. 48  h later Puro-
mycin (5  μg/ml) was added to the transfected cells for 
14 days. To induce shRNA transcription, 5 μg/ml of dox-
ycycline was added to the culture medium for 72 h prior 
to analysis.
Immunoblotting
Whole cell extracts were prepared by lysis in RIPA buffer 
(150 mM NaCl, 1% NP-40, 0.5% Deoxycholic acid, 0.1% 
SDS, 50 mM Tris pH 7.5) and briefly sonicated to disrupt 
genomic DNA, then heated to 100° in SDS and loaded 
onto SDS-PAGE gels. Proteins were transferred to nitro-
cellulose membrane and blocked in 5% milk, 0.1% Tween 
20, PBS for 1  h at room temperature. Blots were incu-
bated at 4  °C overnight with primary antibodies in 10% 
FBS, 0.1% Tween 20. After incubation with DNMT1 anti-
body, blots were washed with PBST and PBS. Antibodies 
used: rabbit polyclonal to DNMT1 (Cell Signaling Tech-
nology, 5032 (D63A6) 1:2500 dilution), rabbit polyclonal 
(See figure on next page.) 
Fig. 1 Cell-cycle independent expression of DNMT1 and the characteristics of the (GK) repeats in DNMT1. a Pulse labeling of cycling mouse 3T3 cell 
with BrdU followed by fixation and staining with antibodies to BrdU and DNMT1 shows that DNMT1 is present in non-S phase cells (identified by 
lack of BrdU staining) at levels comparable to S phase cells as previously reported [30]. b Domain organization of mammalian DNMT1. NLS: nuclear 
localization sequence. RFTS: replication focus targeting sequence. CXXC: Zinc-containing domain that binds to unmethylated CpG sites in double 
stranded DNA. Autoinhibitory: An acidic linker interposed between DNA and the active site of DNMT1 when the CXXC domain is bound to unmeth-
ylated DNA. BAH1 and 2: Bromo-adjacent homology domains that are of unknown function in DNMT1 but are involved in binding to specific histone 
modifications in other proteins. (GK): The run of alternating glycine and lysine amino acids at the junction between the N-terminal regulatory and 
C-terminal catalytic domains of DNMT1. Methyltransferase domain: Catalytic domain related in sequence and structure to eukaryotic and prokaryotic 
DNA (cytosine-5) methyltransferases. c Alignment of (GK) repeats of DNMT1 homologs from mammals, insects, and plants, and with the N-terminal 
tails of histones H2A, H2AZ, and H4. GK dipeptides are outlined in red; the related AK dipeptides are outlined in blue. d Structure of autoinhibited 
form of human DNMT1 in complex with unmethylated DNA to show spatial relationships of domains diagrammed in (b). The protein shown was 
truncated just N-terminal of the CXXC domain prior to crystallization. The (GK) repeats were unstructured in all the crystallographic studies of 
DNMT1; they are shown here roughly to scale in an arbitrary position 
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to USP7 (Bethyl Laboratories, IHC00018; 1:5000 dilu-
tion), rabbit polyclonal to HA tag (Abcam, ab9110, 
1:5000), rabbit polyclonal to UHRF1 (Bethyl Laborato-
ries, A301-470A, 1:1000), mouse monoclonal to alpha-
tubulin (Abcam, ab7291, 1:10,000).
Three independent biological replicates were per-
formed. DNMT1 and tubulin levels were quantified using 
ImageJ. Statistical analysis was performed using the two-
tailed t test.
Methylation analysis
Genomic DNA was extracted by digestion with pro-
teinase K and RNase A followed by phenol/chloroform 
extraction and isopropanol precipitation. Genomic DNA 
was digested for two rounds with methylation-sensitive 
enzyme HpaII, its isoschizomer MspI as a control, or 
McrBC (all from NEB). DNA was quantified and ran 
on 0.8% agarose gel, which was stained with ethidium 
bromide.
Southern blot analysis was performed with IAP probes 
generated by PCR. Primers used for probe amplification: 
probe IAP F (GGTAAACAAATAATCTGCGC); probe 
IAP R (CTGGTAATGGGCTGCTTCTTCC). DNA in 
agarose gels was transferred to a Nytran SPC membrane 
(GE Healthcare) overnight in 10  ×  SSPE buffer. After 
crosslinking, membrane was prehybridized with 6X SSC, 
5X Denhardts, 1% SDS, 10% Dextran Sulfate for 1 h at 45° 
and incubated overnight with IAP probe at 45°. Mem-
branes were washed once with 2X SSC, 0.5% SDS; 2X 
with 1X SSC, 0.5% SDS, and 1X with 0.2X SSC, 0.5% SDS.
Global levels of DNA methylation were quantified 
using LUminometric Methylation Assay (LUMA) as 
described previously [21]. 400  ng of genomic DNA was 
digested with MspI/EcoRI and HpaII/EcoRI in parallel. 
The overhangs from the enzymatic digestion were quan-
tified by Pyrosequencing (PyroMark Q24, Qiagen) with 
the dispensation order: GTCACAGTGT. Global DNA 
methylation levels were calculated from the peak heights 
at positions 3,4,7,8 using the following formula:
Statistical analysis was performed on biological repli-
cates using the two-tailed t test.
Immunofluorescence
ES cells were cultured on glass slides. For the PCNA 
immunostaining, cells were treated with 0.5% Triton 
X-100 in CSK buffer (100  mM NaCl, 300  mM sucrose, 
10  mM PIPES [piperazine-N,N-bis(2-ethanesulfonic 
acid)], pH 6.8, 3  mM MgCl2, 1  mM EGTA) for 30  s 
Global methylation (%)
= [1− (HpaII ΣG/ΣT )/(MspIΣG/ΣT )]× 100
at 4  °C, and then treated with methanol for 20  min at 
− 20 °C [22].
Cells were permeabilized/blocked in Block solution 
(5% Donkey serum, 0.3% Triton, 1X PBS) and then incu-
bated overnight with primary antibody diluted in Block 
solution at 4  °C. The following primary antibodies were 
used: mouse monoclonal to PCNA (Abcam, ab29, 1:500 
dilution), rabbit polyclonal to USP7 (Bethyl Laboratories, 
IHC00018; 1:100 dilution).
Cells were washed ten times with PBS and incubated 
for 1 h at room temperature with the following second-
ary antibodies diluted in Block buffer: Cy3-conjugated 
donkey anti-mouse (Jackson ImmunoResearch; 1:200 
dilution) and IgM Alexa 488–conjugated IgG donkey 
anti-rabbit (Jackson ImmunoResearch; 1:500 dilution). 
Slides were subsequently washed with PBS, counter-
stained with Hoechst 33,342 (Invitrogen) and mounted 
with Vectashield mounting medium (Vector Labs).
Statistical analysis
Statistical data were calculated for groups with normal 
distributions and similar variances. Variation within each 
group of data is reported as standard deviation. ‘n’ repre-
sents the number of biological replicates. p values were 
calculated using the two-tailed t test. The R program was 
used to ensure that n  =  2 was sufficient to establish a 
power of 0.8.
Results
Ablation of USP7 does not affect stability or function 
of DNMT1
Mouse embryonic fibroblasts (MEFs) homozygous for 
Floxed alleles of Usp7 were transfected with an expres-
sion construct that encoded SV40 large T antigen, then 
infected with a recombinant Adenovirus that drives 
expression of GFP and Cre recombinase. Cultures that 
showed near-complete infection as measured by GFP 
expression were cultured for 3–5  days and evaluated 
for expression of USP7 and DNMT1 by immunoblot. 
As shown in Fig. 2a, levels of DNMT1 were not affected 
when USP7 was reduced to undetectable levels. Three 
independent biological replicates were performed, and 
DNMT1 and tubulin levels were quantified using ImageJ. 
Statistical analysis was performed using the two-tailed t 
test, and the p value was > 0.7. USP7 was present at nor-
mal levels in embryonic stem (ES) cells null for Dnmt1 
(Fig.  2c). Global methylation levels were assessed by 
digesting genomic DNA with the methylation-sensi-
tive restriction endonuclease HpaII, its isoschizomer 
MspI as a control, and McrBC, which digests meth-
ylated DNA. Methylation levels were quantified by 
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LUminometric Methylation Assay (LUMA) that uses 
methylation-sensitive enzymes HpaII and MspI followed 
by Pyrosequencing which quantitates the number of 
HpaII cleavage events [21]. As shown in Fig.  2d, global 
levels of DNA methylation were not notably affected by 
the removal of USP7, which is consistent with the lack 
of effect on DNMT1 levels upon removal of USP7. The 
human lung carcinoma cell line H1299 was transfected 
with an expression cassette that drives expression of an 
inducible USP7 shRNA and a stable cell line was derived. 
The shRNA produced is complementary to nucleotides 
2766–2748 of transcript variant 1 and caused strong 
repression of all Usp7 transcript variants. This inducible 
system allows simultaneous induction of shRNA within 
the entire cell population. As shown in Fig. 2b, shRNA-
mediated reduction in USP7 to undetectable levels did 
not affect expression of DNMT1 or UHRF1. Figure  2e 
shows that global DNA methylation was not measurably 
affected by the loss of USP7 expression. Figure 2f shows 
quantification of genomic methylation levels by LUMA. 
MEF cells lacking USP7 showed similar methylation to 
wild-type MEFs (p = 0.08), and H1299 cells with severe 
reduction in USP7 levels exhibit no difference in methyl-
ation as compared to control H1299 cells (p = 1.0). These 
genetic data indicate that removal of USP7 does not lead 
to a significant reduction in DNMT1 or in global DNA 
methylation.
Mutation of GK repeats results in normal stability 
and activity of DNMT1
To further investigate the role of the reported interac-
tion of USP7 with the (GK) repeats of DNMT1 [10], we 
Fig. 2 Ablation of USP7 does not affect steady-state level of DNMT1 or global DNA methylation. a MEFs that lack USP7 after Cre-mediated excision 
of a Floxed allele of Usp7 show normal levels of DNMT1 (lane 2) but no detectable USP7 protein. Biological replicates are shown as Experiments 
1 and 2. b Normal expression of DNMT1 and UHRF1 in human H1299 lung carcinoma cells containing an inducible shRNA against USP7 mRNA. 
Ablation of USP7 has no detectable effect on expression of other proteins. c Normal steady-state expression of USP7 in the absence of DNMT1 in 
ES cells. d Normal DNA methylation in MEFs that lack USP7. McrBC cleaves methylated DNA; HpaII cleaves unmethylated DNA at CCGG sites; MspI 
cleaves CCGG sites whether methylated or unmethylated. DNA from wild-type and Usp7−/− MEFs show similar patterns of resistance to both McrBC 
and HpaII. e Removal of USP7 by an inducible shRNA against USP7 from H1299 human lung carcinoma cells does not affect DNA methylation levels 
as assessed by resistance of DNA to HpaII. f LUMA analysis shows that DNA methylation is not measurably affected by removal of USP7. n = 2 (bio-
logical replicates). Error bars show standard deviations, center value is mean, and p values were calculated using the two-tailed t test
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substituted the lysine residues within the (GK) repeats 
that have been reported to undergo acetylation [22, 23] 
with glutamines (Fig. 3a), which cannot be acetylated and 
have been proposed to mimic acetylated lysines and to 
block the in vitro interaction of USP7 and DNMT1 [10]. 
Expression constructs that directed production of wild 
type (GK) or (GK)→(GQ) DNMT1 were transfected 
into Dnmt1-null ES cells and stable clones established as 
described [19]. Expression was driven by 12 kb of DNA 5′ 
of the Dnmt1 gene, which contains the Dnmt1 promoter 
and other regulatory sequences and has been shown to 
drive expression of DNMT1 to wild-type levels [19, 20]. 
As shown in Fig.  3b, the (GK) and (GQ) proteins were 
expressed at similar levels, even though the (GQ) substi-
tution has been reported to be unable to bind to USP7 
and according to previous reports would have been 
expected to be degraded [10]. Figure 3c also shows that 
the GK and GQ proteins were equally effective in rescu-
ing global DNA methylation after expression in Dnmt1-
null ES cells and that rescue of methylation of the IAP 
retrotransposon is equivalent when the (GK) and (GQ) 
variants of DNMT1 are expressed. Methylation levels by 
LUMA assay showing no significant difference between 
(GK) and (GQ) rescued ES cells (p  =  0.18). The data 
of Figs.  2 and 3 indicate that the steady-state levels of 
DNMT1 are independent of USP7, that removal of USP7 
does not affect global DNA methylation, and that substi-
tution of the lysines in the (GK) repeats of DNMT1 that 
have been reported to be required for the DNMT1-USP7 
interaction and stabilization of DNMT1 [10] do not affect 
the expression or biological function of DNMT1.
USP7 localizes to replication foci independently of DNMT1
It was reported that the recruitment of USP7 to replica-
tion foci is dependent on the (GK) repeats of DNMT1 
[10]. We tested for recruitment of USP7 to replication 
foci in ES cells that were wild type or null for Dnmt1. As 
shown in Fig.  4, USP7 colocalized with the replication 
focus marker PCNA independently of DNMT1. These 
data show that USP7 is not recruited to replication foci 
by DNMT1 and are consistent with a recent report in 
which USP7 is required to maintain an enrichment in 
Fig. 3 Substitution of lysines by glutamines within (GK) repeats does not affect DNMT1 stability or function. a Positions of GK→GQ substitutions 
within the (GK) repeats of DNMT1. The substituted lysines correspond to those reported to be acetylated in vivo and to block the interaction of 
DNMT1 and USP7 in vitro. b Normal stability of GK→GQ DNMT1 in stably transfected Dnmt1-null ES cells. Two independent transfected clones are 
shown. c Normal methylation of genomic DNA as measured by resistance to HpaII in stably transfected ES cells at left; at center, equal methylation 
of IAP retrotransposon DNA by wild-type and GK→GQ DNMT1. “WT SssI” indicates DNA that had been methylated at all CpG sites by treatment with 
M.SssI. At right is LUMA analysis of DNA methylation in (GK) versus (GQ) DNMT1 expression cells. n = 3 (biological replicates). Error bars indicate 
standard deviations. The center value is mean, and p values were calculated using the two-tailed t test
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SUMOylation and depletion of ubiquitylation at sites of 
DNA replication that is essential for DNA replication 
[15] and for the removal of minichromosome mainte-
nance complex binding protein (MCM-BP) from chro-
matin after DNA replication [24], which occurs after 
completion of maintenance DNA methylation. DNMT1 
is not required for DNA replication, as shown by normal 
DNA replication in Dnmt1-null ES cells [19].
Discussion
Several lines of evidence indicate that USP7 does not 
control cell cycle-dependent levels of DNMT1 in vivo as 
had been claimed. First, DNMT1 is not degraded after 
S phase in cycling cells; in Xenopus extracts DNMT1 
levels and chromatin loading are unperturbed upon the 
inhibition of proteasome activity [25]. Second, DNMT1 
levels are independent of the presence of USP7, as shown 
Fig. 4 USP7 is recruited to replication foci in the absence of DNMT1. Replication foci where identified by staining for the replication factor PCNA. 
Colocalization of USP7 and PCNA is clearly apparent in both wild type (top three rows) and Dnmt1-null (bottom three rows) ES cell nuclei
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in Fig. 2. Third, substitution of the GK repeats with GQ 
repeats, which prevents the acetylation of DNMT1, does 
not affect steady-state levels of DNMT1 (Fig. 3). Fourth, 
USP7 localizes to replication foci independently of 
DNMT1 (Fig.  4). Fifth, modification of the endogenous 
Dnmt1 locus so as to delete the first 118 amino acids of 
DNMT1 caused the accumulation and persistence of 
truncated but fully active DNMT1 to  ~  5 times normal 
levels [26]. This is the only genetically defined region 
of DNMT1 that affects protein stability. However, this 
shortened and stabilized form of DNMT1 is produced 
only in growing oocytes and has not been detected in 
somatic cells [27].
The (GK) repeats are both highly basic and unstruc-
tured; they are therefore capable of adopting many con-
formations and would be expected to bind nonspecifically 
in vitro to many proteins that contain acidic pockets, as is 
the case for USP7. Furthermore, prior studies expressed 
tagged recombinant DNMT1 in wild-type cells where 
the relative amounts of tagged recombinant DNMT1 to 
endogenous wild-type DNMT1 were not reported [10].
Despite the numerous reports of post-translational 
regulation of DNMT1 expression in an acetylation-
dependent manner [7–11], strong evidence indicates 
that DNMT1 levels are normally controlled at the tran-
scriptional rather than the post-translational level. Cells 
heterozygous for loss-of-function mutations at Dnmt1 
express one-half the amount of DNMT1 protein when 
compared to wild-type cells [28], and mice that con-
tain additional copies of the Dnmt1 gene overexpress 
DNMT1 protein [29]. DNMT1 is overexpressed in Friend 
Murine Erythroleukemia cells as a result of spontane-
ous amplification of the Dnmt1 gene in this cell type [3]. 
DNMT1 is present in nuclei at constant levels through-
out the cell cycle and is recruited to replication foci dur-
ing S phase [30]. DNMT1 is down-regulated in  G0 cells, 
but this is likely to occur at the transcriptional level [17]. 
Treatment of cells with drugs that induce entry into  G0 
phase will cause a reduction in DNMT1 levels due to cell 
cycle effects rather than a direct effect on DNMT1 stabil-
ity [17]. There is no direct evidence of a post-translational 
mechanism that compensates for reduced or increased 
DNMT1 transcript levels, and changes in Dnmt1 gene 
dosage result in proportionate increases or decreases in 
DNMT1 protein level.
Many studies have tried to identify regulators of 
DNMT1 using immunoprecipitation assays; the only 
confirmed regulator of DNMT1, the E3 ubiquitin ligase 
UHRF1, was identified in a genetic screen, not an interac-
tion screen. Null alleles of Uhrf1 phenocopy null alleles of 
Dnmt1 in mice [31]. Recent studies suggest that UHRF1 
acts through binding and ubiquitylation of histones and 
other proteins at the replication foci [32, 33] rather than 
by effects on DNMT1 expression.
Conclusions
These findings indicate that the steady-state level of 
DNMT1 protein in cycling cell populations is controlled 
at the level of transcription and that the interaction of 
DNMT1 and USP7 is unlikely to play a major role in 
DNMT1 homeostasis.
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